NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Duoning Biotechnology

Duoning Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://www.duoningbio.com/

Last Round

Private Equity

Mar 1, 2023

Est. Valuation

$1.46B

Total Funding Raised

$16.34M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Duoning Biotechnology is a biotechnology company that provides comprehensive solutions for the research, development, and commercialization of biologics products, offering a wide range of reagents, consumables, and equipment to support bioprocess and laboratory R&D.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

bioprocessing solutionsbioprocessingbiotech consumablessingle-use technologiescell culture mediabiopharma supply chainbiologics manufacturingbiotech manufacturingbiotech lab equipmentfiltration systemslab supplybioprocess validationbioprocess engineeringsingle-cell sortingbiotech vendor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Duoning Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Duoning Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Duoning Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 1, 2023
Series CNov 24, 2021
Series BDec 30, 2020
Series A ExtensionApr 24, 2019
Series ASep 29, 2018

Duoning Biotechnology Investors

Notable investors and investment history

Duoning Biotechnology investors
InvestorRounds
Huitianfu Fund Management Co., Ltd.Series C
Lake Bleu CapitalSeries C, Series B
GL Capital GroupSeries C
Ally Bridge GroupSeries A Extension
HongShanSeries C
HongShanSeries C, Series B
China Asset Management Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 189% MoM.

Duoning Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Duoning Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Duoning Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range24
Year Founded2005
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.